←
Maraver Lab736 posts
Maraver Lab avatar✓

Maraver Lab ✓

@MaraverLab

Antonio Maraver, PhD, is Head of “Oncogenic pathways in lung cancer” lab at Montpellier Cancer Research Institute (IRCM)

◷ Joined September 2019▧ 33 Photos and videos
Han Li Pasteur avatar
⟳ Maraver Lab retweeted
Han Li Pasteur@HanLi_Pasteur·Feb 18

Senescence links regeneration to oncogenic vulnerability. Our latest work demonstrates that senescence drives postpartum mammary involution while simultaneously creating a transient microenvironment permissive for tumor initiation. #senescence, #postpartum, #breastcancer

Julien Mazieres avatar
⟳ Maraver Lab retweeted
Julien Mazieres@JulienMazieres·27 Sep 2025

Tiens, ça faisait longtemps que je n’étais pas allé sur le site de @PhilipMorris_FR . Jamais déçu par cette communication cynique. Vous n’oubliez pas dans votre synthèse l’empreinte sur la santé de vos produits et les millions de morts ? 🤔

Post attachment
TAONas-LUAD avatar
⟳ Maraver Lab retweeted
TAONas-LUAD@TaonasL·8 Jul 2025

Therapeutic oligonucleotides are gaining ground in oncology. They offer a new way to target cancer at the genetic level — with precision and flexibility that traditional drugs often can’t match. Watch this video to learn more▶️ #oncology #RNAtherapeutics #biotech #TAONASLUAD

0:35
Maraver Lab avatar
Maraver Lab@MaraverLab·3 Apr 2025

As you know, ferroptosis inhibitors are still far from being used in the clinic, but our findings provide a new way to sensitize cells against them which could facilitate their clinical translation, at least to treat the leading cause of death by cancer in the world, i.e., lung.

Maraver Lab avatar
Maraver Lab@MaraverLab·3 Apr 2025

4. We further dissect the mechanism and uncovered that FMO4 binds MAT2A, leading to the stabilization of the MAT2A-MAT2B complex in order to promote the generation of cysteine that in turn regenerates reduced glutathione to allow GPX4-driven protection against ferroptosis.

Maraver Lab avatar
Maraver Lab@MaraverLab·3 Apr 2025

2. We demonstrate that FMO is critically required for KRAS-driven lung cancer generation and maintenance in mice in vivo. 3. We found that FMO4 deletion in lung cancer sensitizes cells against ferroptosis both in vitro and in vivo, revealing FMO4 as an interesting cancer target.

Maraver Lab avatar
Maraver Lab@MaraverLab·3 Apr 2025

1. We first found that flavin containing monooxygenase 4 (FMO4) is highly expressed in lung tumors and very low expressed in healthy lung in mouse and lung cancer patients where its expression negatively correlates with patients’ survival.

Maraver Lab avatar
Maraver Lab@MaraverLab·3 Apr 2025

Thrilled to present our study aiming to identify new vulnerabilities in lung cancer: biorxiv.org/content/10.1101/… Joining forces from mouse genetics, thoracic oncology, metabolism, and AlphaFold fields we dissected the role of a largely unknown but essential protein in cancer, FMO4 🧵